1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,
NAN 190,
NAN-190,
NAN-190 hydrobromide,
115388-32-4,
115338-32-4,
2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)isoindoline-1,3-dione hydrobromide,
NAN 190 hydrobromide,
NAN-190,
NAN-190 (hydrobromide),
CHEBI:64123,
1-(2-Methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine hydrobromide,
1-(2-Methoxyphenyl)-4-(4-phthalimidobutyl)piperazinehydrobromide,
1-(2-Methoxyphenyl)-4-(4-phthalimidobutyl)piperazine hydrobromide,
1-(2-Methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine hydrobromide,
2-(4-(4-(2-METHOXYPHENYL)PIPERAZIN-1-YL)BUTYL)-ISOINDOLINE-1,3-DIONE HYDROBROMIDE,
2-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]isoindole-1,3-dione hydrobromide,
2-{4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}-1H-isoindole-1,3(2H)-dione hydrobromide,
1H-Isoindole-1,3(2H)-dione, 2-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)-, monohydrobromide,
SR-01000075563,
2-{4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}isoindole-1,3-dione hydrobromide,
NAN190 hydrobromide,
C23H28BrN3O3,
MLS000859948,
AC1L332K,
SCHEMBL4083153,
CHEMBL1256701,
DTXSID5042588,
CTK8B9474,
Tox21_500876,
2511AA,
ANW-62583,
BN0367,
CN-027,
HY-19818A,
MFCD00078590,
AKOS016004193,
CCG-222180,
CS-5473,
EBD2206388,
LP00876,
NCGC00094200-01,
NCGC00261561-01,
AC-27421,
LS-84602,
SMR000326807,
AX8233420,
RT-014661,
TX-011461,
B6349,
EU-0100876,
FT-0764658,
ST24039357,
N 3529,
J-003283,
SR-01000075563-1,
SR-01000075563-3,
1-(2-Methoxyphenyl)-4-(phthalimidobutyl)piperazine hydrobromide,
1-[4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)butyl]-4-(2-methoxyphenyl)piperazin-1-ium bromide,
1H-Isoindole-1,3(2H)-dione, 2-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-, hydrobromide (1:1),
Nan 190,
C23H27N3O3.BrH,
C23-H27-N3-O3.Br-H,
CID107966,
A13417,
1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,